GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (FRA:OCD1) » Definitions » Float Percentage Of Total Shares Outstanding

ChromaDex (FRA:OCD1) Float Percentage Of Total Shares Outstanding : 73.66% (As of May. 16, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ChromaDex Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ChromaDex's float shares is 55.64 Mil. ChromaDex's total shares outstanding is 75.54 Mil. ChromaDex's float percentage of total shares outstanding is 73.66%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ChromaDex's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ChromaDex's Institutional Ownership is 13.62%.

ChromaDex Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

ChromaDex's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=55.64/75.54
=73.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChromaDex (FRA:OCD1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (FRA:OCD1) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ANIX NKTX INO PRLD IFRX VXRT THRX PRQR MNOV AADI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
CDXC:USA
Address
10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024
Website
https://www.chromadex.com
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segment namely Consumer Products, Ingredients segment and Analytical Reference Standards and Services. Majority of the revenue is earned from Consumer Products segment.

ChromaDex (FRA:OCD1) Headlines

No Headlines